- Home
- ATHM vs IMVT Comparison
ATHM vs IMVT Comparison
Compare ATHM & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHM
- IMVT
- Stock Information
- Founded
- ATHM 2008
- IMVT 2018
- Country
- ATHM China
- IMVT United States
- Employees
- ATHM N/A
- IMVT N/A
- Industry
- ATHM EDP Services
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATHM Technology
- IMVT Health Care
- Exchange
- ATHM Nasdaq
- IMVT Nasdaq
- Market Cap
- ATHM 2.9B
- IMVT 2.8B
- IPO Year
- ATHM 2013
- IMVT N/A
- Fundamental
- Price
- ATHM $25.43
- IMVT $15.80
- Analyst Decision
- ATHM Hold
- IMVT Buy
- Analyst Count
- ATHM 3
- IMVT 10
- Target Price
- ATHM $32.00
- IMVT $40.14
- AVG Volume (30 Days)
- ATHM 361.5K
- IMVT 1.3M
- Earning Date
- ATHM 07-30-2025
- IMVT 08-05-2025
- Dividend Yield
- ATHM 6.74%
- IMVT N/A
- EPS Growth
- ATHM N/A
- IMVT N/A
- EPS
- ATHM 1.80
- IMVT N/A
- Revenue
- ATHM $948,713,568.00
- IMVT N/A
- Revenue This Year
- ATHM N/A
- IMVT N/A
- Revenue Next Year
- ATHM $2.08
- IMVT N/A
- P/E Ratio
- ATHM $14.27
- IMVT N/A
- Revenue Growth
- ATHM N/A
- IMVT N/A
- 52 Week Low
- ATHM $21.89
- IMVT $12.72
- 52 Week High
- ATHM $34.70
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- ATHM 47.33
- IMVT 53.39
- Support Level
- ATHM $25.32
- IMVT $15.11
- Resistance Level
- ATHM $26.11
- IMVT $17.08
- Average True Range (ATR)
- ATHM 0.58
- IMVT 0.76
- MACD
- ATHM 0.09
- IMVT -0.00
- Stochastic Oscillator
- ATHM 42.68
- IMVT 47.56
About ATHM Autohome Inc.
Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead generation service provider with 30% market share, in terms of media services and lead generation revenue, in China's online auto platform media advertising market.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.